Brian Stoltz

American organic chemist From Wikipedia, the free encyclopedia

Brian Stoltz

Brian M. Stoltz is currently a professor of chemistry at the California Institute of Technology.[2] The primary focus of his research is chemical synthesis with an emphasis on expanding the scope of allylic alkylation for the preparation of complex molecules possessing unique structural, biological, and physical properties. His research involves the total synthesis of natural products such as dragmacidin F[3] and (–)-cyanthiwigin F,[4] and development of synthetic reactions to access quaternary stereocenters.[5] Specifically, he has focused on the allylic alkylation of enolates, developing an enantioselective variant in 2004.[6]

Quick Facts Born, Nationality ...
Brian Stoltz
Thumb
Born
Brian M. Stoltz

(1970-11-12) November 12, 1970 (age 54)
NationalityAmerican
Alma materIndiana University of Pennsylvania (B.S., 1993)
Yale (Ph.D., 1997)
AwardsFellow of the American Association for the Advancement of Science
Scientific career
FieldsChemistry
InstitutionsCalifornia Institute of Technology
Doctoral advisorJohn L. Wood
Other academic advisorsE. J. Corey
Doctoral students
Websitewww.cce.caltech.edu/content/brian-m-stoltz
Close

Education

Stoltz received undergraduate degrees in Chemistry and German from Indiana University of Pennsylvania in 1993. As an undergraduate he spent a year abroad at the Ludwig Maximilian University of Munich. He went on to earn his M.S. and Ph.D. at Yale University,[7] where he studied organic chemistry under the supervision of John L. Wood, completing his studies in 1997. Upon completion of his graduate work, he held an NIH post-doctoral fellowship appointment in the laboratory of E. J. Corey at Harvard University from 1998 to 2000.

Career and research

Stoltz is the Editor-in-Chief of Tetrahedron. At present[when?] he is also an associate editor for the Beilstein Journal of Organic Chemistry.[8]

Awards and honors

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.